Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease

To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dupuytren Contracture Connective Tissue Diseases Contracture Fibroma Muscular Diseases Musculoskeletal Diseases Neoplasms Neoplasms by Histologic Type Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Neoplasms, Fibrous Tissue Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

dupuytrens disease
xiapex treatment

Exclusion criteria

demens/other psychiatric diseases

Treatment and study plan

Xiapex

Drug

Follow-up of effect of treatment

Primary outcomes

Change in extension deficit from baseline to FU in MCP and PIP joints after treatment

Time frame: Minimum one year after treatment

Sponsors and collaborators

Lead sponsor

Jeppe Lange

Other

Registry information

Official study title

Collagenase Clostridium Histolytic is a Common Treatment of MCP and PIP Joint Contractures in Dupuytren Disease. A 1 to 4 Year Followup Study of 198 Joints

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2019
First posted: Nov 6, 2017
Registry last updated: Apr 22, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed